01 — At a Glance
The Wellness Company That Acquired Two Companies Instead of Focusing
- 52-Week High / Low₹531 / ₹311
- FY25 Revenue (Full Year)₹3,389 Cr
- FY25 PAT (Full Year)₹207 Cr
- Full-Year EPS (FY25)₹6.51
- Q3 EPS (Annualised)-₹5.00
- Book Value₹179
- Price to Book2.18x
- Debt₹3,042 Cr
- Debt / Equity0.53x
- Interest Coverage5.20x
Red Alert: Zydus Wellness reported a net loss of ₹40 crores in Q3 FY26 (Dec 2025) on ₹965 crore revenue. Yes, you read that right. 113% sales growth. Negative profit. The company acquired Naturell (₹390 Cr) and Comfort Click (GBP 239m ≈ ₹2,400+ Cr) within six months, then acted shocked that reported earnings turned negative. Amortization charges, bridge loan interest at 5%, and exceptional items have turned this company into an accounting black hole. Stock down 23% in 6 months. Welcome to growth at any cost.
02 — Introduction
The “Wellness” Company That’s Making Investors Sick
Zydus Wellness. Remember when their biggest problem was figuring out how to sell more Complan and Nycil without breaking the bank? Those were simpler times. Innocent times. Times before they decided that 2025 was the year to spend ₹2,800 crores acquiring two companies while their base business margins were already under pressure.
The company started life as “Cadila Healthcare’s consumer division” — slicing out the good bits: Sugar Free (95% market share in sugar substitutes), Glucon-D (59% in glucose powders), Everyuth (46% in facial scrubs), Nycil (34% in prickly heat powder), and Complan (4% in nutritional drinks, trending down). It’s a portfolio of brands with fortress market shares in categories that nobody actually wants to think about buying.
For years, that worked fine. Steady 6% revenue growth. Modest 6% ROE. Consistent dividend payouts. The stock climbed politely. Then in late 2024, new management walked in with a PowerPoint deck and a vision: “We’re going to build a global wellness company.” Two acquisitions later, they’ve turned their balance sheet into a casino chip holder and their P&L into a cautionary tale.
Q3 FY26 delivered exactly what such a strategy deserves: 113% revenue growth, net losses, margin collapse, and a stock down 23% in six months. But management swears this is “the bottom.” Let’s verify that claim with data instead of hope.
Feb 2026 Concall Summary: Management admitted FY26 will be “the bottom” and expects EPS accretion from FY27 onwards. They also promise better segmental disclosure “by end of the year” — which is the corporate equivalent of “the check is in the mail.”
03 — Business Model: WTF Do They Even Own Now?
The Legacy Business Is Being Drowned By Strategic Ambitions
Zydus Wellness has two distinct operating models now, and they are fundamentally at war with each other.
The Legacy India Business (Sugar Free, Complan, Glucon-D, Nycil, Everyuth): This is a classic consumer staples model. Market-leading brands. Distribution-intensive (1,700+ distributors, 2,000 field reps). Seasonal revenue (Nycil peaks in summers; Glucon-D in winters). Modest growth (6% CAGR last 3 years), high margins (historically 16–18% operating margin), and cash-generative. Think: your grandmother’s cupboard brands.
The M&A Pivot (RiteBite via Naturell, Comfort Click via August 2025): Two acquisitions in rapid succession. RiteBite (protein bars/nutrition snacking) plugs into the global health-snacking mega-trend but doesn’t exist in India’s retail yet. Comfort Click is a UK-based VMS (vitamins, minerals, supplements) e-commerce platform with ₹134 crore UK revenue, present in multiple European markets via D2C and marketplace channels. Both are high-margin (Comfort Click at ~66–67% gross margin) but high-burn (digital marketing costs, amortization charges, integration overhead).
The Structural Problem: Legacy brands need slow, steady, asset-lite distribution optimization. Comfort Click needs aggressive digital spend, brand building, and geographic expansion. You can’t run both playbooks on the same team simultaneously. The company is trying. It’s not working. Q3 is exhibit A.
Sugar Free Market Share95.9%Stranglehold Status
Everyuth Scrub Share48.5%Growth Limbo
Glucon-D Share58.8%Seasonal Dependency
Capital Allocation Roast: The company spent ₹2,800+ crores on two acquisitions. The legacy business generated ₹380 crore operating profit in FY25. It would take 7+ years for the base business to generate the cash needed to pay for these deals. The assumption is that Comfort Click becomes a unicorn. In 2025-funded debt, at 5% interest on bridge loans. Bet of the century? Or financial engineering gone rogue?
💬 If you owned Zydus Wellness stock pre-acquisition, did you consent to a ₹2,800 crore YOLO bet on UK wellness e-commerce? Drop your thoughts.
04 — Financials Overview
Q3 FY26: The Numbers That Broke The Internet
Continue reading with a premium membership.
